We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Highlights Range of Automatic Diagnostic Analyzers at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022
Print article
Image: The compact, fully automated RX Monaco comprises an extensive test menu (Photo courtesy of Randox)
Image: The compact, fully automated RX Monaco comprises an extensive test menu (Photo courtesy of Randox)

Randox Laboratories (Crumlin, UK) is highlighting its extensive range of diagnostic analyzers at this year's MEDICA, the world's largest annual medical technology trade fair taking place from 14-17 November in Düsseldorf, Germany.

Among its innovative products being presented by Randox at MEDICA 2022 is the RX misano, a high performance semi-automated clinical chemistry analyzer. The RX misano shines a new light on semi-automated clinical chemistry testing with increased auto-functionality and groundbreaking technology and is capable of high standard, precise results at a competitive price per test. It expands testing capabilities with the ability to run both routine and specialized tests including chemistries, specific proteins, antioxidants, veterinary and diabetes testing, and can analyze a variety of sample types, including serum, plasma, and urine.

Randox is also exhibiting the RX monaco which comprises an extensive test menu covering routine chemistries, specific proteins, lipids, antioxidants, diabetes and veterinary testing with emergency and STAT sampling. The RX monaco is ideal for low to mid volume clinical chemistry testing consolidating routine and specialized testing on one efficient and easy to use platform. Offering the ultimate in convenience, performance and confidence, the RX monaco is capable of performing 170 photometric tests per hour. The RX monaco combines robust hardware and intuitive software offering customers choice to suit their unique circumstances, where they can choose between a benchtop or floor standing system.

Also on display at the Randox booth at MEDICA 2022 is the RX daytona+ fully automated analyzer which can perform a wide range of niche and specialized routine chemistries, specific proteins, lipids, therapeutic drugs, antioxidants, diabetes and veterinary testing. The RX daytona+ also has direct HbA1c testing capabilities, eliminating sample pre-dilution and ultimately saving time in the laboratory, and can analyze a variety of sample types including serum, plasma urine, CSF and whole blood. The fully automated, random access platform can deliver a high level of precision, accuracy and reliability with the ability to perform emergency STAT sampling. The most versatile analyzer in its class, the RX daytona+ is capable of performing 270 photometric tests per hour and up to 450 tests per hour with ISE.

Related Links:
Randox Laboratories

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.